Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Chronic Post-Surgical Pain
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine Hydrochloride Nasal Spray Dexmedetomidine is a selective alpha-2 adrenergic agonist primarily used for its sedative, anxiolytic, and analgesic effects. It works by inhibiting the release of norepinephrine in the central nervous system, leading to sedation, decreased anxiety, and reduced pain sensitivity. When used intranasally, it can offer an effective, non-invasive method for sedating patients and improving sleep quality, particularly in perioperative settings.

DRUG

Saline solution

The saline solution will be used as a placebo, and the same device will be employed for intranasal administration.

Trial Locations (1)

100730

Department of Anesthesiology, Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

National Cancer Center/National Cancer Clinical Medical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

UNKNOWN

lead

Peking Union Medical College Hospital

OTHER